Paul Krogstad1, Kunjal Patel, Brad Karalius, Rohan Hazra, Mark J Abzug, James Oleske, George R Seage, Paige L Williams, William Borkowsky, Andrew Wiznia, Jorge Pinto, Russell B Van Dyke. 1. aDepartment of Pediatrics (Infectious Diseases) bDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, California cDepartment of Epidemiology, Center for Biostatistics in AIDS Research (CBAR), Harvard School of Public Health, Boston, Massachusetts dEunice Kennedy Shriver National Institute of Child Health & Human Development, Bethesda, Maryland eUniversity of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado fDepartment of Pediatrics, Rutgers New Jersey Medical School, Newark, New Jersey gNew York University School of Medicine hAlbert Einstein College of Medicine, New York City, New York, USA iDepartment of Pediatrics, Federal University of Minas Gerais, Minas Gerais, Brazil jTulane University School of Medicine, New Orleans, Louisiana, USA.
Abstract
OBJECTIVES: Some perinatally infected children do not regain normal CD4(+) T-cell counts despite suppression of HIV-1 plasma viremia by antiretroviral therapy (ART). The frequency, severity and significance of these discordant treatment responses remain unclear. DESIGN: We examined the persistence of CD4(+) lymphocytopenia despite virologic suppression in 933 children (≥ 5 years of age) in the USA, Latin America and the Caribbean. METHODS: CD4(+) T-cell trajectories were examined and Kaplan-Meier methods used to estimate median time to CD4(+) T-cell count at least 500 cells/μl. RESULTS: After 1 year of virologic suppression, most (99%) children achieved a CD4(+) T-cell count of at least 200 cells/μl, but CD4(+) T-cell counts remained below 500 cells/μl after 1 and 2 years of virologic suppression in 14 and 8% of children, respectively. Median times to first CD4(+) T-cell count at least 500 cells/μl were 1.29, 0.78 and 0.46 years for children with less than 200, 200-349 and 350-499 cells/μl at the start of virologic suppression. New AIDS-defining events occurred in nine children, including four in the first 6 months of virologic suppression. Other infectious and HIV-related diagnoses occurred more frequently and across a wide range of CD4(+) cell counts. CONCLUSION: ART improved CD4(+) cell counts in most children, but the time to CD4(+) cell count of at least 500 cells was highly dependent upon baseline immunological status. Some children did not reach a CD4(+) T-cell count of 500 cells/μl despite 2 years of virologic suppression. AIDS-defining events occurred in 1% of the population, including children in whom virologic suppression and improved CD4(+) T-cell counts were achieved.
OBJECTIVES: Some perinatally infected children do not regain normal CD4(+) T-cell counts despite suppression of HIV-1 plasma viremia by antiretroviral therapy (ART). The frequency, severity and significance of these discordant treatment responses remain unclear. DESIGN: We examined the persistence of CD4(+) lymphocytopenia despite virologic suppression in 933 children (≥ 5 years of age) in the USA, Latin America and the Caribbean. METHODS:CD4(+) T-cell trajectories were examined and Kaplan-Meier methods used to estimate median time to CD4(+) T-cell count at least 500 cells/μl. RESULTS: After 1 year of virologic suppression, most (99%) children achieved a CD4(+) T-cell count of at least 200 cells/μl, but CD4(+) T-cell counts remained below 500 cells/μl after 1 and 2 years of virologic suppression in 14 and 8% of children, respectively. Median times to first CD4(+) T-cell count at least 500 cells/μl were 1.29, 0.78 and 0.46 years for children with less than 200, 200-349 and 350-499 cells/μl at the start of virologic suppression. New AIDS-defining events occurred in nine children, including four in the first 6 months of virologic suppression. Other infectious and HIV-related diagnoses occurred more frequently and across a wide range of CD4(+) cell counts. CONCLUSION: ART improved CD4(+) cell counts in most children, but the time to CD4(+) cell count of at least 500 cells was highly dependent upon baseline immunological status. Some children did not reach a CD4(+) T-cell count of 500 cells/μl despite 2 years of virologic suppression. AIDS-defining events occurred in 1% of the population, including children in whom virologic suppression and improved CD4(+) T-cell counts were achieved.
Authors: Richard M Rutstein; Kelly A Gebo; Patricia M Flynn; John A Fleishman; Victoria L Sharp; George K Siberry; Stephen A Spector Journal: Med Care Date: 2005-09 Impact factor: 2.983
Authors: W V Raszka; G A Meyer; N J Waecker; D P Ascher; R A Moriarty; G W Fischer; M L Robb Journal: Pediatr Infect Dis J Date: 1994-01 Impact factor: 2.129
Authors: David M Moore; Robert S Hogg; Benita Yip; Evan Wood; Mark Tyndall; Paula Braitstein; Julio S G Montaner Journal: J Acquir Immune Defic Syndr Date: 2005-11-01 Impact factor: 3.731
Authors: Jason C Lee; Maria Ines Boechat; Marvin Belzer; Joseph A Church; Jaime De Ville; Karin Nielsen; Stephanie Weston; Yongzhi Geng; Theresa Dunaway; Christina Kitchen; Paul A Krogstad Journal: AIDS Date: 2006-03-21 Impact factor: 4.177
Authors: Patricia M Flynn; Bret J Rudy; Steven D Douglas; Janet Lathey; Stephen A Spector; Jaime Martinez; Margarita Silio; Marvin Belzer; Lawrence Friedman; Lawrence D'Angelo; James McNamara; Janice Hodge; Michael D Hughes; Jane C Lindsey Journal: J Infect Dis Date: 2004-06-18 Impact factor: 5.226
Authors: Salvador Resino; Elena Seoane; Alicia Pérez; Ezequiel Ruiz-Mateos; Manuel Leal; Maria A Muñoz-Fernández Journal: BMC Infect Dis Date: 2006-07-13 Impact factor: 3.090
Authors: Anne M Neilan; Brad Karalius; Kunjal Patel; Russell B Van Dyke; Mark J Abzug; Allison L Agwu; Paige L Williams; Murli Purswani; Deborah Kacanek; James M Oleske; Sandra K Burchett; Andrew Wiznia; Miriam Chernoff; George R Seage; Andrea L Ciaranello Journal: JAMA Pediatr Date: 2017-05-01 Impact factor: 16.193
Authors: Adam W Bartlett; Pagakrong Lumbiganon; Nia Kurniati; Tavitiya Sudjaritruk; Thahira J Mohamed; Rawiwan Hansudewechakul; Penh S Ly; Khanh H Truong; Thanyawee Puthanakit; Lam V Nguyen; Kulkanya Chokephaibulkit; Viet C Do; Nagalingeswaran Kumarasamy; Nik Khairulddin Nik Yusoff; Moy S Fong; Dewi K Watu; Revathy Nallusamy; Annette H Sohn; Matthew G Law Journal: J Adolesc Health Date: 2019-08-05 Impact factor: 5.012
Authors: Christian R Aguilera-Sandoval; Otto O Yang; Nebojsa Jojic; Pietro Lovato; Diana Y Chen; Maria Ines Boechat; Paige Cooper; Jun Zuo; Christina Ramirez; Marvin Belzer; Joseph A Church; Paul Krogstad Journal: AIDS Date: 2016-03-13 Impact factor: 4.177
Authors: Emily Adland; Luisa Mori; Leana Laker; Anna Csala; Maximilian Muenchhoff; Alice Swordy; Masa Mori; Philippa Matthews; Gareth Tudor-Williams; Pieter Jooste; Philip Goulder Journal: AIDS Date: 2018-07-17 Impact factor: 4.177
Authors: Yuping Fu; Yan Liu; Zhiying Liu; Lifeng Liu; Lin Yuan; Xizhao An; Jufeng Sun; Tong Zhang; Hao Wu; Shi Lian; Bin Su Journal: Biomed Res Int Date: 2020-12-03 Impact factor: 3.411